Reduce treatment time without losing effectiveness
Following correctly the prescribed treatment is essential for its effectiveness.
We participated in the conversation Hepatitis C: Challenge for health, promoted by Fuinsa and Servimedia and that took place in the Press Association of Madrid.
TG4040 is a modified Ankara vaccine virus that expresses the hepatitis C virus NS3, NS4 and NS5B proteins (therapeutic vaccine). The Foundation participated in a phase II clinical trial in patients with chronic hepatitis C.
A new study by members of the Foundation for the Study of Viral Hepatitis on the presence of hidden hepatitis C in patients with chronic hepatitis B is published in the Journal of Medical Microbiology.
In January of this year two important studies of Hepatitis C treatment without interferon have been published. So Kowdley et al (NEJMed, 222-232) have used three inhibitory drugs from different areas of the C virus.
Currently there are antiviral treatments against chronic hepatitis C (pegylated interferon + ribavirin + inhibitors) with a favorable response in 75% of cases. However, these treatments can have important side effects and contraindications for its administration.